Rhenman & Partners Asset Management Ab Dynavax Technologies Corp Transaction History
Rhenman & Partners Asset Management Ab
- $1.2 Billion
- Q3 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 1,190,000 shares of DVAX stock, worth $15.3 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
1,190,000
Previous 1,232,361
3.44%
Holding current value
$15.3 Million
Previous $13.8 Million
4.21%
% of portfolio
1.1%
Previous 1.37%
Shares
22 transactions
Others Institutions Holding DVAX
# of Institutions
276Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$281 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$161 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$118 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$107 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$98.8 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.63B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...